Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
To compare nitroglycerin and terbutaline for intrapartum fetal heart rate...
Brief Summary
Official Title: “Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation”
To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
- Study Primary Completion Date: July 2006
Intervention(s) in this Clinical Trial
- Drug: Terbutaline
- Terbutaline 250 micrograms intravenously for intrapartum fetal resuscitation. Nitroglycerine 400 micrograms intravenously for intrapartum fetal resuscitation.
Arms, Groups and Cohorts in this Clinical Trial
- Active Comparator: Terbutaline
- Active Comparator: Nitroglycerine
Outcome Measures for this Clinical Trial
Primary Measures
- resolution of abnormal fetal heart tracing
- Time Frame: Administration of study medication to resolution of abnormal fetal heart tracing or operative delivery.
Safety Issue?: Yes
- Time Frame: Administration of study medication to resolution of abnormal fetal heart tracing or operative delivery.
Secondary Measures
- cesarean section rate
- Time Frame: Data analysis
Safety Issue?: No
- Time Frame: Data analysis
- operative vaginal delivery rate
- Time Frame: Data analysis
Safety Issue?: No
- Time Frame: Data analysis
- neonatal outcomes
- Time Frame: time of delivery to time of discharge
Safety Issue?: No
- Time Frame: time of delivery to time of discharge
Criteria for Participation in this Clinical Trial
Inclusion Criteria::
- nonreassuring fetal heart rate tracing
- Exclusion Criteria:- maternal cardiac disease, placental abruption, intrauterine growth restriction, prior cesarean section
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Stanford University Other
Overall Clinical Trial Officials and Contacts
Yasser Yehia El-Sayed Principal Investigator Stanford University
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00185887
Study ID Number: 79504
ClinicalTrials.gov Identifier: NCT00185887
Health Authority: United States: Institutional Review Board
American Journal of Obstetrics and Gynecology. 2007 Oct;197(4):414.el-6
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00185887
